| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |